Peter Kröner joined the Management Board of Airway Medix
The Supervisory Board appointed Peter Kröner, founder of Kröner Medizintechnik with more than 30 years in medical technology, to the Management Board. He is responsible for the commercialization of the products, in particular in the DACH region and the United States.
Warsaw, November 20, 2023: The Supervisory Board of Airway Medix S.A. has appointed Peter Kröner to the Company's Management Board. He brings over 30 years of experience in the MedTech industry, with particular emphasis on marketing, sales and distribution of medical equipment worldwide. The appointment is the result of an investment agreement under which strategic investors will invest up to EUR 2 million.
Peter Kröner, founder of Kröner Medizintechnik, will be responsible for the commercialization of the projects, focusing on the DACH and US markets. Together with new team members, he will manage the sales, distribution and supply chain management processes. His experience also includes participation in investment agreement negotiations and the due diligence process.
The partners CoOpera Finanzierungen Deutschland and Kröner Medizintechnik are operationally involved in the development and commercialization of projects.
About Airway Medix S.A.: Airway Medix S.A. focuses on the research, development and commercialization of innovative single-use devices for mechanically ventilated patients in Intensive Care Units (ICUs), as well as life-threatening patients and anesthesiology departments. The products offered by Airway Medix address the most pressing clinical needs and fill a gap in current medical devices. Airway Medix S.A. has been listed on the Warsaw Stock Exchange since 2014.
Press releases are published as issued by Airway Medix S.A. Product statements follow the instructions for use.
